1. Home
  2. GEHC vs RJF Comparison

GEHC vs RJF Comparison

Compare GEHC & RJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEHC
  • RJF
  • Stock Information
  • Founded
  • GEHC 1892
  • RJF 1962
  • Country
  • GEHC United States
  • RJF United States
  • Employees
  • GEHC N/A
  • RJF N/A
  • Industry
  • GEHC Computer Software: Prepackaged Software
  • RJF Investment Bankers/Brokers/Service
  • Sector
  • GEHC Technology
  • RJF Finance
  • Exchange
  • GEHC Nasdaq
  • RJF Nasdaq
  • Market Cap
  • GEHC 33.1B
  • RJF 31.4B
  • IPO Year
  • GEHC N/A
  • RJF N/A
  • Fundamental
  • Price
  • GEHC $73.46
  • RJF $152.45
  • Analyst Decision
  • GEHC Buy
  • RJF Buy
  • Analyst Count
  • GEHC 9
  • RJF 12
  • Target Price
  • GEHC $86.11
  • RJF $181.00
  • AVG Volume (30 Days)
  • GEHC 3.9M
  • RJF 1.2M
  • Earning Date
  • GEHC 10-29-2025
  • RJF 10-22-2025
  • Dividend Yield
  • GEHC 0.19%
  • RJF 1.26%
  • EPS Growth
  • GEHC 32.35
  • RJF 6.19
  • EPS
  • GEHC 4.83
  • RJF 10.30
  • Revenue
  • GEHC $20,246,000,000.00
  • RJF $14,028,000,000.00
  • Revenue This Year
  • GEHC $6.41
  • RJF $11.86
  • Revenue Next Year
  • GEHC $4.44
  • RJF $7.82
  • P/E Ratio
  • GEHC $14.97
  • RJF $15.37
  • Revenue Growth
  • GEHC 3.51
  • RJF 9.62
  • 52 Week Low
  • GEHC $57.65
  • RJF $117.57
  • 52 Week High
  • GEHC $94.80
  • RJF $177.66
  • Technical
  • Relative Strength Index (RSI)
  • GEHC 47.81
  • RJF 34.21
  • Support Level
  • GEHC $70.04
  • RJF $153.27
  • Resistance Level
  • GEHC $75.59
  • RJF $167.94
  • Average True Range (ATR)
  • GEHC 1.93
  • RJF 3.80
  • MACD
  • GEHC -0.27
  • RJF -0.58
  • Stochastic Oscillator
  • GEHC 49.67
  • RJF 0.00

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

About RJF Raymond James Financial Inc.

Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. The firm maintains an extensive catalogue of products and services across its business lines. However, the wealth management franchise generates the bulk of its revenues and earnings through a vast network of nearly 8,800 independent and employee-affiliated advisors, who collectively manage over $1.7 trillion in client assets as of fiscal year-end 2025. While Raymond James maintains a global footprint, the company derives over 90% of its revenue, and an even larger percentage of its operating income, from the United States.

Share on Social Networks: